Author:
Elez Elena,Baraibar Iosune
Reference10 articles.
1. Immunotherapy in colorectal cancer: rationale, challenges and potential;Ganesh;Nat Rev Gastroenterol Hepatol,2019
2. The consensus molecular subtypes of colorectal cancer;Guinney;Nat Med,2015
3. Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial;Antoniotti;Lancet Oncol,2022
4. Adverse immunoregulatory effects of 5FU and CPT11 chemotherapy on myeloid-derived suppressor cells and colorectal cancer outcomes;Kanterman;Cancer Res,2014
5. VEGFA–VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer;Terme;Cancer Res,2013
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献